Skip to main navigation Skip to search Skip to main content

Non-cell-autonomous tumor suppression by p53

  • Amaia Lujambio
  • , Leila Akkari
  • , Janelle Simon
  • , Danielle Grace
  • , Darjus F. Tschaharganeh
  • , Jessica E. Bolden
  • , Zhen Zhao
  • , Vishal Thapar
  • , Johanna A. Joyce
  • , Valery Krizhanovsky
  • , Scott W. Lowe

Research output: Contribution to journalArticlepeer-review

700 Scopus citations

Abstract

The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.

Original languageEnglish
Pages (from-to)449-460
Number of pages12
JournalCell
Volume153
Issue number2
DOIs
StatePublished - 11 Apr 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Non-cell-autonomous tumor suppression by p53'. Together they form a unique fingerprint.

Cite this